When Do Doctors Recommend Genetic Testing for Gastro-Intestinal Cancers?

When Do Doctors Recommend Genetic Testing for Gastro-Intestinal Cancers?

Gastrointestinal (GI) cancers, which affect organs like the stomach, colon, and pancreas, are a major health concern. While many factors contribute to their development, a person's genetic makeup can play a crucial role. Understanding your genetic risk can be a powerful tool for prevention and early detection. This is why genetic testing is increasingly used in oncology.

What is Genetic Risk in GI Cancers?

Most cancers occur by chance and are termed "sporadic." However, about 5% to 10% of GI cancers are "hereditary," meaning they are caused by an inherited gene mutation passed down through families. These inherited mutations can significantly increase a person’s lifetime risk of developing certain cancers.

Genetic testing helps identify such inherited mutations. For individuals with a strong family history of GI cancer, testing offers vital information that guides medical decisions. Early identification of genetic risk supports personalized screening plans, preventive measures, and targeted treatment options if cancer develops.

When Do Doctors Recommend Genetic Testing?

Doctors may recommend genetic testing when certain risk factors are present, such as:

  • Early-Onset Cancer: Being diagnosed with GI cancer (like colorectal cancer) before age 50.
  • Multiple Cancers: Having more than one type of cancer, such as colorectal and uterine cancer.
  • Significant Family History: Multiple close relatives diagnosed with GI cancers on the same side of the family.
  • Specific Cancer Patterns: Family patterns suggestive of hereditary cancer syndromes like Lynch syndrome.
  • Rare GI Cancers: Certain rare cancers known to be linked to inherited mutations.
  • Multiple Polyps: Developing 10 or more colorectal polyps.

Common Hereditary GI Cancer Syndromes

Several hereditary conditions are known to increase the risk of gastrointestinal cancers. Genetic testing identifies mutations linked to these syndromes.

Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer)

Lynch syndrome is the most common hereditary cause of colorectal cancer, resulting from mutations in the MLH1, MSH2, MSH6, PMS2, or EPCAM genes.

  • Associated Cancers: High risk of colorectal cancer (up to 80% lifetime risk), endometrial, ovarian, stomach, small intestine, pancreatic, and urinary tract cancers.
  • When Testing Is Recommended: For individuals diagnosed with colorectal or endometrial cancer under age 50 or with a strong family history.

Familial Adenomatous Polyposis (FAP)

FAP is caused by mutations in the APC gene and leads to hundreds or thousands of polyps in the colon and rectum, usually developing in teenage years.

  • Associated Cancers: Nearly 100% risk of colorectal cancer if untreated; increased risk of stomach, small intestine, and thyroid cancer.
  • When Testing Is Recommended: For individuals with 10–20 or more colorectal polyps or with a family history of FAP.

Hereditary Diffuse Gastric Cancer (HDGC)

HDGC is linked to mutations in the CDH1 gene and greatly increases the risk of diffuse gastric cancer.

  • Associated Cancers: Increased risk of lobular breast cancer in women.
  • When Testing Is Recommended: Two or more family cases of diffuse gastric cancer (one under age 50) or an individual diagnosed before age 40.

Peutz-Jeghers Syndrome (PJS)

PJS is caused by mutations in the STK11 gene. It is identified by special hamartomatous polyps in the GI tract and dark spots on the lips and mouth.

  • Associated Cancers: Higher risk of colon, rectum, stomach, small intestine, pancreas, and breast cancers.
  • When Testing Is Recommended: Testing confirms diagnosis, especially when there is a family history.

The Genetic Testing Process

The genetic testing procedure usually includes:

  1. Genetic Counseling: Reviewing medical and family history, discussing testing options, and understanding outcomes.
  2. Sample Collection: Using a simple saliva or blood sample.
  3. DNA Analysis: Specialized labs check for mutations linked to GI cancer syndromes.
  4. Results & Post-Test Counseling: Explanation of results and guidance on next steps.

A positive result confirms a hereditary cancer risk and helps create a personalized screening plan. A negative result means no mutation was found, but risk may still exist if family history is strong.

Conclusion

Knowing your genetic risk for gastrointestinal cancers is a proactive step toward protecting your health. If you or your family members have a history of GI cancer, discussing genetic testing with a specialist can offer clarity and early intervention opportunities.

Consult with a healthcare provider to determine if genetic testing is right for you. Early evaluation provides peace of mind and helps in long-term health protection.

Recent Blogs

What is Absolute Eosinophil Count (AEC)?

What is Absolute Eosinophil Count (AEC)? A blood test can reveal a great deal...

05-12-2025

ESR Levels: High vs. Low – What They Mean for Your Health

ESR Levels: High vs. Low – What They Mean for Your Health The Erythrocyte...

05-12-2025

How to Choose the Right Blood Test Centre?

How to Choose the Right Blood Test Centre? Choosing the right blood test centre...

05-12-2025

GO BACK TO HOMEPAGE